Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -47.05% is 34% above its 5-year average of -70.98%, near the high end of its 5-year range (-126.69%–-28.49%).
As of the fiscal period ended Tuesday, June 30, 2026. 35.56% above its 12-month average of -73.02%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -47.05%.
RETURN ON INVESTED CAPITAL (ROIC)
-47.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-73.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-73.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-70.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+35.56%
CURRENT VS 3Y AVG
+36.32%
CURRENT VS 5Y AVG
+33.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-31.99%
vs the sector median at left
Whitehawk Therapeutics Inc
Market Cap
$205.80M
Return on Invested Capital (ROIC)
-47.05%
TTM Avg
-73.02%
3Y Avg
-73.88%
5Y Avg
-70.98%
Market Cap
$207.27M
Return on Invested Capital (ROIC)
14.99%
TTM Avg
15.04%
3Y Avg
13.17%
5Y Avg
12.12%
Market Cap
$208.31M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$209.91M
Return on Invested Capital (ROIC)
26.14%
TTM Avg
3.79%
3Y Avg
-12.27%
5Y Avg
-17.37%
Market Cap
$210.41M
Return on Invested Capital (ROIC)
-63.61%
TTM Avg
-17.34%
3Y Avg
-19.38%
5Y Avg
-26.83%
Market Cap
$200.96M
Return on Invested Capital (ROIC)
-71.04%
TTM Avg
-53.65%
3Y Avg
-40.34%
5Y Avg
-35.55%
Market Cap
$210.98M
Return on Invested Capital (ROIC)
-70.80%
TTM Avg
-76.09%
3Y Avg
-51.87%
5Y Avg
-42.00%
Market Cap
$198.33M
Return on Invested Capital (ROIC)
-33.10%
TTM Avg
-20.50%
3Y Avg
-16.94%
5Y Avg
-23.40%
Market Cap
$197.87M
Return on Invested Capital (ROIC)
-33.88%
TTM Avg
-37.38%
3Y Avg
-46.28%
5Y Avg
-37.99%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc (WHWK) | $205.80M | -47.05% | -73.02% | -73.88% | -70.98% |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | 14.99% | 15.04% | 13.17% | 12.12% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $209.91M | 26.14% | 3.79% | -12.27% | -17.37% |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.41M | -63.61% | -17.34% | -19.38% | -26.83% |
| Alector, Inc. (ALEC)vs › | $200.96M | -71.04% | -53.65% | -40.34% | -35.55% |
| Lyell Immunopharma, Inc. (LYEL)vs › | $210.98M | -70.80% | -76.09% | -51.87% | -42.00% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | -33.10% | -20.50% | -16.94% | -23.40% |
| Exagen Inc. (XGN)vs › | $197.87M | -33.88% | -37.38% | -46.28% | -37.99% |
| Niagen Bioscience Inc (NAGE)vs › | $214.24M | 8.84% | 15.21% | -9.34% | -32.56% |
ROIC
-47.0%
ROE
-43.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -47.05% |
| 2026-03-31 | -105.62% |
| 2025-12-31 | -83.93% |
| 2025-09-30 | -69.01% |
| 2025-06-30 | -59.47% |
| 2025-03-31 | -28.49% |
| 2024-12-31 | -126.69% |
| 2024-09-30 | -94.76% |
| 2024-06-30 | -88.91% |
| 2024-03-31 | -81.82% |
| 2023-12-31 | -67.84% |
| 2023-09-30 | -58.49% |
| 2023-06-30 | -48.38% |
| 2023-03-31 | -42.96% |
| 2022-12-31 | -37.90% |
| 2022-09-30 | -35.84% |
| 2022-06-30 | -116.71% |
| 2022-03-31 | -92.46% |
| 2021-12-31 | -77.97% |
| 2021-09-30 | -55.26% |
